
As an Amazon Associate and affiliate partner, Menrva Books earns from qualifying purchases. Learn more
Psychiatric comorbidities such as depression, anxiety and substance use are extremely common amongst people with schizophrenia. They add to poor clinical outcomes and disability, yet are often not at the forefront of the minds of clinicians, who tend to concentrate on assessing and treating the core symptoms of schizophrenia, notably delusions and hallucinations. There is an imperative to assess every patient with schizophrenia for psychiatric comorbidities, as they might masquerade as core psychotic symptoms and also because they warrant treatment in their own right. This volume addresses these issues using a clinical lens informed by the current literature. Published as part of the Oxford Psychiatry Library series, the book serves as a concise and practical reference for busy clinicians.
This volume investigates the critical necessity of identifying and managing psychiatric comorbidities in patients diagnosed with schizophrenia to improve clinical outcomes. The authors, David J. Castle, Peter F. Buckley, and Rachel Upthegrove, leverage their extensive clinical expertise to argue that comorbid conditions like depression and substance use are frequently overlooked in favor of primary psychotic symptoms. By synthesizing current psychiatric literature, the text provides a structured framework for clinicians to integrate comprehensive comorbidity screening into routine practice.
What You Will Find
Experts recognize this volume as a practical, high-utility resource within the Oxford Psychiatry Library series for clinicians seeking to refine their diagnostic approach. Readers frequently note the clinical density of the prose, which prioritizes actionable guidance over theoretical abstraction.
Page Count:
128
Publication Date:
2021-02-14
Publisher:
Oxford University Press
ISBN-10:
0198870337
ISBN-13:
9780198870333
No comments yet. Be the first to share your thoughts!